Publicaciones en colaboración con investigadores/as de University Hospital of Zurich (16)

2022

  1. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry

    Journal of Hepatology, Vol. 76, Núm. 5, pp. 1109-1121

2021

  1. Correction: Current and novel therapeutic opportunities for systemic therapy in biliary cancer (British Journal of Cancer, (2020), 123, 7, (1047-1059), 10.1038/s41416-020-0987-3)

    British Journal of Cancer

  2. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: A systematic review and individual participant data meta-analysis

    Obstetrical and Gynecological Survey

  3. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis

    The Lancet Gastroenterology and Hepatology, Vol. 6, Núm. 7, pp. 547-558

2020

  1. Cholangiocarcinoma 2020: the next horizon in mechanisms and management

    Nature Reviews Gastroenterology and Hepatology, Vol. 17, Núm. 9, pp. 557-588

  2. Current and novel therapeutic opportunities for systemic therapy in biliary cancer

    British Journal of Cancer, Vol. 123, Núm. 7, pp. 1047-1059

2019

  1. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: Results of aggregate and individual patient data meta-analyses

    Obstetrical and Gynecological Survey

  2. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses

    The Lancet, Vol. 393, Núm. 10174, pp. 899-909

2018

  1. Serum IP-10 levels and increased DPPIV activity are linked to circulating CXCR3+ T cells in cholestatic HCV patients

    PLoS ONE, Vol. 13, Núm. 12

2016

  1. Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)

    Nature Reviews Gastroenterology and Hepatology, Vol. 13, Núm. 5, pp. 261-280

2013

  1. Influence of body mass index on the association of weight changes with mortality in hemodialysis patients

    Clinical Journal of the American Society of Nephrology, Vol. 8, Núm. 10, pp. 1725-1733

2004

  1. Temporal expression profiles of organic anion transport proteins in placenta and fetal liver of the rat

    American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 287, Núm. 6 56-6

2003

  1. Effect of ursodeoxycholic acid on the impairment induced by maternal cholestasis in the rat placenta-maternal liver tandem excretory pathway

    Journal of Pharmacology and Experimental Therapeutics, Vol. 305, Núm. 2, pp. 515-524

2002

  1. Carriers involved in targeting the cytostatic bile acid-cisplatin derivatives cis-diammine-chloro-cholylglycinate-platinum(II) and cis-diammine-bisursodeoxycholate-platinum(II) toward liver cells

    Molecular Pharmacology, Vol. 61, Núm. 4, pp. 853-860

2000

  1. Effect of maternal cholestasis on bile acid transfer across the rat placenta-maternal liver tandem

    Hepatology, Vol. 31, Núm. 4, pp. 975-983

  2. Expression of members of the multidrug resistance protein family in human term placenta

    American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 279, Núm. 4 48-4